Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1998 | 1 |
2002 | 1 |
2003 | 1 |
2006 | 1 |
2017 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
The following term was ignored: *
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study.
J Am Heart Assoc. 2022 Mar;11(5):e020745. doi: 10.1161/JAHA.121.020745. Epub 2022 Feb 18.
J Am Heart Assoc. 2022.
PMID: 35179040
Free PMC article.
Eslicarbazepine acetate and carotid intima-media thickness in epileptic patients.
Serrano-Castro PJ, Fernández-Pérez J, López-González FJ, Toledo-Argany M, Estévez-María JC, Arjona-Padillo A, Bertol-Alegre V, Mauri-Llerda JA, Tortosa-Conesa D, Ruiz-Giménez J, Querol-Pascual R, García-Martínez A, Molto-Jorda JM, Payán-Ortiz M, Maestre-Moreno JF, Galván-Espinosa J; ESL-LIPID Study Group.
Serrano-Castro PJ, et al.
Epilepsy Res. 2017 Dec;138:81-87. doi: 10.1016/j.eplepsyres.2017.10.018. Epub 2017 Oct 29.
Epilepsy Res. 2017.
PMID: 29096133
Item in Clipboard
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.
Keech A, Colquhoun D, Best J, Kirby A, Simes RJ, Hunt D, Hague W, Beller E, Arulchelvam M, Baker J, Tonkin A; LIPID Study Group.
Keech A, et al.
Diabetes Care. 2003 Oct;26(10):2713-21. doi: 10.2337/diacare.26.10.2713.
Diabetes Care. 2003.
PMID: 14514569
Clinical Trial.
Item in Clipboard
Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
Tonkin AM, Eckermann S, White H, Friedlander D, Glasziou P, Magnus P, Kirby A, Mulray S, Denton M, Sallaberger M, Hunt D, Simes J; LIPID Study Group.
Tonkin AM, et al.
Am Heart J. 2006 Jun;151(6):1305-12. doi: 10.1016/j.ahj.2005.07.014.
Am Heart J. 2006.
PMID: 16781242
Clinical Trial.
Item in Clipboard
Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease).
LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease).
Lancet. 2002 Apr 20;359(9315):1379-87. doi: 10.1016/S0140-6736(02)08351-4.
Lancet. 2002.
PMID: 11978335
Clinical Trial.
Item in Clipboard
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
N Engl J Med. 1998 Nov 5;339(19):1349-57. doi: 10.1056/NEJM199811053391902.
N Engl J Med. 1998.
PMID: 9841303
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite